- Home
- BBCP vs ENGN Comparison
BBCP vs ENGN Comparison
Compare BBCP & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBCP
- ENGN
- Stock Information
- Founded
- BBCP 1983
- ENGN 1999
- Country
- BBCP United States
- ENGN Canada
- Employees
- BBCP N/A
- ENGN N/A
- Industry
- BBCP Engineering & Construction
- ENGN
- Sector
- BBCP Consumer Discretionary
- ENGN
- Exchange
- BBCP Nasdaq
- ENGN Nasdaq
- Market Cap
- BBCP 370.5M
- ENGN 293.1M
- IPO Year
- BBCP 2017
- ENGN N/A
- Fundamental
- Price
- BBCP $7.15
- ENGN $8.65
- Analyst Decision
- BBCP Buy
- ENGN Strong Buy
- Analyst Count
- BBCP 4
- ENGN 8
- Target Price
- BBCP $7.67
- ENGN $30.38
- AVG Volume (30 Days)
- BBCP 93.4K
- ENGN 167.2K
- Earning Date
- BBCP 01-09-2025
- ENGN 01-27-2025
- Dividend Yield
- BBCP N/A
- ENGN N/A
- EPS Growth
- BBCP N/A
- ENGN N/A
- EPS
- BBCP 0.26
- ENGN N/A
- Revenue
- BBCP $434,594,000.00
- ENGN N/A
- Revenue This Year
- BBCP N/A
- ENGN N/A
- Revenue Next Year
- BBCP N/A
- ENGN N/A
- P/E Ratio
- BBCP $27.43
- ENGN N/A
- Revenue Growth
- BBCP N/A
- ENGN N/A
- 52 Week Low
- BBCP $5.05
- ENGN $4.42
- 52 Week High
- BBCP $8.48
- ENGN $18.40
- Technical
- Relative Strength Index (RSI)
- BBCP 73.87
- ENGN 57.04
- Support Level
- BBCP $7.05
- ENGN $8.00
- Resistance Level
- BBCP $7.37
- ENGN $8.89
- Average True Range (ATR)
- BBCP 0.27
- ENGN 0.59
- MACD
- BBCP 0.11
- ENGN 0.06
- Stochastic Oscillator
- BBCP 88.42
- ENGN 58.70
About BBCP Concrete Pumping Holdings Inc.
Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators position it to deliver concrete placement solutions. The company's operating segment includes U.S. Concrete Pumping; U.K. Operations; U.S. Concrete Waste Management Services and Corporate. It generates maximum revenue from the U.S. Concrete Pumping segment. Geographically, it generates majority of the revenue from its business in United States.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.